Supplement Ingredients Should Meet GRAS Standard - FDA's Lake
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplement ingredients should adhere to the "generally recognized as safe" standard applicable to conventional food ingredients even though it is not required under DSHEA, FDA Center for Food Safety & Applied Nutrition's Robert Lake, PhD, advised at a Food & Drug Law Institute seminar on dietary ingredients in Washington, D.C. Nov. 8.
You may also be interested in...
"Functional foods" mfrs. group developing structure/function claims proposal comments.
NEW DIETARY INGREDIENTS ASSOCIATION TO FOCUS ON "FUNCTIONAL FOODS" and the furthering of research on the interaction between food components and disease reduction or prevention. The Research-based Dietary Ingredients Association (RbDIA) will undertake a multi-faceted agenda to represent the interests of manufacturers and developers of "functional foods." The association hopes to facilitate communication between, pharmaceutical, dietary supplement and food manufacturers that are developing functional food products.
Commission rejects evidence summaries in supplement claims notification.
SUPPLEMENT "STATEMENT OF AFFIRMATION" FOR SAFETY/EFFICACY ADVISED by the President's Commission on Dietary Supplement Labels final report issued Nov. 24 at the group's last meeting. Dietary supplement manufacturers voluntarily "should provide statements of affirmation that they have substantiation for the statement of nutritional support and that the product does not represent a significant or unreasonable risk of illness under conditions of use recommended or suggested in labeling," either in the notification letter to FDA required for all structure/function claims by the Dietary Supplement Health & Education Act or in a separate public notice, the report states.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC